# Incretin Effect and Use After Clinical Islet Transplantation

> **NCT00768651** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 8 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT00768651
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00768651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00768651, "Incretin Effect and Use After Clinical Islet Transplantation". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00768651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*